EUVIMEDEUVIMED entdecken
Crossref

AlphaFold2 Insights into c‐Abl Transactivation by Adaptor c‐Crk or Abi‐1: Structural Forms, Active Site Types, and Multiple SH3 ‐ PxxPxK /R Interactions

Tomoyuki Shishido iD, Masahiro Fujihashi

Genes to Cells · 2026

DOI: 10.1111/gtc.70088 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes to Cells, 2026. Verfasst von Tomoyuki Shishido und 1 weiteren Autor:innen. Beteiligte Einrichtung: SeemeData Labs, Inc., Tokyo, Japan. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-abl, Proto-Oncogene Proteins c-crk, Transcriptional Activation, Adaptor Proteins, Signal Transducing. Die Arbeit nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study used AlphaFold2 to investigate allosteric structural changes during c‐Abl transactivation. Two structural forms of c‐Abl (positions of SH2 and SH3 domains relative to kinase domain) and four active site types (types 0–3) were identified. Key interactions were predicted between the c‐Crk SH3 domain (CrkSH3N) and four c‐Abl PxxPxK/R motifs, particularly the 612–617 motif, where residue 617R plays a critical role. A residue‐level analysis using our developed PAE_json2excel tool supported these findings. The predicted CrkSH3N position relative to c‐Abl kinase domain varied. The c‐Abl's active site displayed structural flexibility, categorized into four types on the basis of the presence or absence of residues 286E and 381D within the hydrogen‐bond distance (3.2 Å) to the side‐chain nitrogen of 271K: type 0 (neither 286E nor 381D), type 1 (286E present), type 2 (381D present), and type 3 (both 286E and 381D present). The Abl(SH3W110K) may coincide with the presence of type 1 in the c‐Abl mutant alone and may display types 0–3 when complexed. Multiple interactions between CrkSH3N and c‐Abl PxxPxK/R motifs may coincide with the presence of type 2. These findings provide new insights into the dynamic flexibility of the c‐Abl active site during c‐Abl transactivation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-ablProto-Oncogene Proteins c-crkTranscriptional ActivationAdaptor Proteins, Signal TransducingCytoskeletal Proteinssrc Homology DomainsCatalytic DomainHumansProtein BindingModels, Molecular

Stichwörter der Autor:innen

Abi‐1AlphaFold2adaptorc‐Abl transactivationc‐Crk

Substanzen

Proto-Oncogene Proteins c-ablProto-Oncogene Proteins c-crkAdaptor Proteins, Signal TransducingCytoskeletal Proteins

Autor:innen und Institutionen

  • SeemeData Labs, Inc., Tokyo, Japan.
  • Shishido & Associates, Tokyo, Japan.
  • Division of Food Science and Biotechnology, Graduate School of Agricultural Sciences, Kyoto University, Kyoto, Japan.

ORCID-Profile: Tomoyuki Shishido

Zitieren

APA

Shishido, T., & Fujihashi, M. (2026). AlphaFold2 Insights into c‐Abl Transactivation by Adaptor c‐Crk or Abi‐1: Structural Forms, Active Site Types, and Multiple SH3 ‐ PxxPxK /R Interactions. Genes to Cells. https://doi.org/10.1111/gtc.70088

Vancouver

Shishido T, Fujihashi M. AlphaFold2 Insights into c‐Abl Transactivation by Adaptor c‐Crk or Abi‐1: Structural Forms, Active Site Types, and Multiple SH3 ‐ PxxPxK /R Interactions. Genes to Cells. 2026. doi:10.1111/gtc.70088

BibTeX
@article{Shishido2026,
  author = {Shishido, Tomoyuki and Fujihashi, Masahiro},
  title = {AlphaFold2 Insights into c‐Abl Transactivation by Adaptor c‐Crk or Abi‐1: Structural Forms, Active Site Types, and Multiple SH3 ‐ PxxPxK /R Interactions},
  journal = {Genes to Cells},
  year = {2026},
  doi = {10.1111/gtc.70088}
}
Kostenlos starten →